Liao, Y., Guo, Z., Xia, X., Liu, Y., Huang, C., Jiang, L., . . . Huang, H. (2019). Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer. J Exp Clin Cancer Res.
Citación estilo ChicagoLiao, Yuning, Zhiqiang Guo, Xiaohong Xia, Yuan Liu, Chuyi Huang, Lili Jiang, Xuejun Wang, Jinbao Liu, and Hongbiao Huang. "Inhibition of EGFR Signaling With Spautin-1 Represents a Novel Therapeutics for Prostate Cancer." J Exp Clin Cancer Res 2019.
Cita MLALiao, Yuning, et al. "Inhibition of EGFR Signaling With Spautin-1 Represents a Novel Therapeutics for Prostate Cancer." J Exp Clin Cancer Res 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.